State Street Corp Hutchmed (China) LTD Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Hutchmed (China) LTD stock. As of the latest transaction made, State Street Corp holds 336,865 shares of HCM stock, worth $5.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

336,865

Previous 347,603 3.09%

Holding current value

$5.96 Million

Previous $5.01 Million 1.16%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$13.09 - $16.75 $140,560 - $179,861	-10,738 Reduced 3.09%	336,865 $5.07 Million
Q4 2024 Feb 14, 2025	SELL	$14.25 - $21.35 $27,374 - $41,013	-1,921 Reduced 0.55%	347,603 $5.01 Million
Q3 2024 Nov 14, 2024	BUY	$16.03 - $20.31 $49,340 - $62,514	3,078 Added 0.89%	349,524 $6.83 Million
Q2 2024 Aug 14, 2024	BUY	$16.36 - $21.78 $45,677 - $60,809	2,792 Added 0.81%	346,446 $5.93 Million
Q1 2024 May 15, 2024	SELL	$12.08 - $18.56 $61,801 - $94,952	-5,116 Reduced 1.47%	343,654 $5.77 Million
Q4 2023 Feb 14, 2024	SELL	$16.25 - $20.23 $718,006 - $893,862	-44,185 Reduced 11.24%	348,770 $6.32 Million
Q3 2023 Nov 14, 2023	SELL	$11.85 - $16.95 $489,416 - $700,051	-41,301 Reduced 9.51%	392,955 $6.66 Million
Q2 2023 Aug 14, 2023	SELL	$10.78 - $17.73 $503,425 - $827,991	-46,700 Reduced 9.71%	434,256 $5.21 Million
Q1 2023 May 15, 2023	SELL	$13.02 - $19.87 $286,804 - $437,696	-22,028 Reduced 4.38%	480,956 $6.26 Million
Q4 2022 Feb 14, 2023	SELL	$7.65 - $15.51 $5.26 Million - $10.7 Million	-687,930 Reduced 57.76%	502,984 $7.43 Million
Q3 2022 Nov 15, 2022	BUY	$8.63 - $15.52 $98,528 - $177,191	11,417 Added 0.97%	1,190,914 $10.6 Million
Q2 2022 Aug 15, 2022	SELL	$8.59 - $20.77 $288,306 - $697,103	-33,563 Reduced 2.77%	1,179,497 $14.9 Million
Q1 2022 May 16, 2022	SELL	$15.52 - $35.65 $810,594 - $1.86 Million	-52,229 Reduced 4.13%	1,213,060 $23 Million
Q4 2021 Feb 14, 2022	BUY	$28.89 - $35.33 $2.16 Million - $2.64 Million	74,715 Added 6.28%	1,265,289 $44.4 Million
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $2.37 Million - $2.85 Million	66,385 Added 5.91%	1,190,574 $43.6 Million
Q2 2021 Aug 16, 2021	BUY	$23.7 - $39.27 $953,759 - $1.58 Million	40,243 Added 3.71%	1,124,189 $44.1 Million
Q1 2021 May 17, 2021	BUY	$27.01 - $36.8 $425,110 - $579,195	15,739 Added 1.47%	1,083,946 $30.6 Million
Q4 2020 Feb 16, 2021	SELL	$27.51 - $34.36 $871,241 - $1.09 Million	-31,670 Reduced 2.88%	1,068,207 $34.2 Million
Q3 2020 Nov 10, 2020	BUY	$25.8 - $34.61 $900,497 - $1.21 Million	34,903 Added 3.28%	1,099,877 $35.5 Million
Q2 2020 Aug 14, 2020	BUY	$17.65 - $28.05 $72,100 - $114,584	4,085 Added 0.39%	1,064,974 $29.4 Million
Q1 2020 May 11, 2020	BUY	$15.19 - $29.51 $16.1 Million - $31.3 Million	1,060,889 New	1,060,889 $18.9 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

6.43M

Call Options Held

9.9K

Put Options Held

9.6K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.06B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Hutchmed (China) LTD Transaction History